A multicentre prospective open-label study assessing efficacy and safety of a triple-secured fibrinogen concentrate in the treatment of postpartum haemorrhage

AS Ducloy-Bouthors; F Broisin; C Teboul; A Jaffry; T Waegemans; B Padrazzi

首页> 外文期刊>Critical care : >A multicentre prospective open-label study assessing efficacy and safety of a triple-secured fibrinogen concentrate in the treatment of postpartum haemorrhage

【24h】

A multicentre prospective open-label study assessing efficacy and safety of a triple-secured fibrinogen concentrate in the treatment of postpartum haemorrhage

机译：一项多中心前瞻性开放性研究，评估三安全性纤维蛋白原浓缩物治疗产后出血的有效性和安全性

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Critical care :》 |2008年第2期|共页
作者
AS Ducloy-Bouthors; F Broisin; C Teboul; A Jaffry; T Waegemans; B Padrazzi;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类护理学;
关键词

相似文献

外文文献
中文文献
专利

1. An open-label, multicentre study to assess the safety and efficacy of a novel reflux suppressant (Gaviscon Advance) in the treatment of heartburn during pregnancy. [J] . Lindow SW, Regnell P, Sykes J, International journal of clinical practice . 2003,第3期

机译：一项开放性，多中心研究，旨在评估新型反流抑制剂（Gaviscon Advance）在妊娠期烧心治疗中的安全性和有效性。
2. Fibrinogen concentrate versus placebo for treatment of postpartum haemorrhage: study protocol for a randomised controlled trial [J] . Nadine Aawar, Raza Alikhan, Daniel Bruynseels, Trials . 2015,第1期

机译：浓缩纤维蛋白原与安慰剂治疗产后出血：一项随机对照试验的研究方案
3. The FIB-PPH trial: fibrinogen concentrate as initial treatment for postpartum haemorrhage: study protocol for a randomised controlled trial [J] . Anne J Wikkelsoe, Arash Afshari, Jakob Stensballe, Trials . 2012,第1期

机译：FIB-PPH试验：浓缩纤维蛋白原作为产后出血的初始治疗：一项随机对照试验的研究方案
4. An open-label, multicenter, randomized,comparative, safety, efficacy, cycle control,and quality of life study of CTR 25, Alesse ,and Ortho Tri-Cyclen [C] . Victoria Davis, Brian Hauck, Sheila Dunn, World Congress on Fertility and Sterility . 2004

机译：开放标签，多中心，随机，比较，安全，疗效，循环控制和CTR 25，Alesse和Ortho Tri-Cyclen的生命研究
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. A multicentre prospective open-label study assessing efficacy and safety of a triple-secured fibrinogen concentrate in the treatment of postpartum haemorrhage [O] . AS Ducloy-Bouthors, F Broisin, C Teboul, 2008

机译：一项多中心前瞻性开放性研究评估三安全性纤维蛋白原浓缩物治疗产后出血的有效性和安全性
7. Fibrinogen concentrate versus placebo for treatment of postpartum haemorrhage: study protocol for a randomised controlled trial [O] . Nadine Aawar, Raza Alikhan, Daniel Bruynseels, 2015

机译：浓缩纤维蛋白原与安慰剂治疗产后出血：一项随机对照试验的研究方案

A multicentre prospective open-label study assessing efficacy and safety of a triple-secured fibrinogen concentrate in the treatment of postpartum haemorrhage

著录项

相似文献

相关主题

期刊订阅